TY  - GEN
AU  - Prey,S
AU  - Ezzedine,K
AU  - Doussau,A
AU  - Grandoulier,A-S
AU  - Barcat,D
AU  - Chatelus,E
AU  - Diot,E
AU  - Durant,C
AU  - Hachulla,E
AU  - de Korwin-Krokowski,J-D
AU  - Kostrzewa,E
AU  - Quemeneur,T
AU  - Paul,C
AU  - Schaeverbeke,T
AU  - Seneschal,J
AU  - Solanilla,A
AU  - Sparsa,A
AU  - Bouchet,S
AU  - Lepreux,S
AU  - Mahon,F-X
AU  - Chene,G
AU  - Taïeb,A
TI  - Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial
SN  - 1365-2133
PY  - 2013///0411
KW  - Adult
KW  - Aged
KW  - Benzamides
KW  - Double-Blind Method
KW  - Female
KW  - Fibrosis
KW  - drug therapy
KW  - Humans
KW  - Imatinib Mesylate
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - therapeutic use
KW  - Platelet-Derived Growth Factor
KW  - metabolism
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Quality of Life
KW  - Scleroderma, Diffuse
KW  - Skin
KW  - pathology
KW  - Transforming Growth Factor beta
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2133.2012.11186.x
ER  -